International Society for Stem Cell Research

International Society for Stem Cell Research
Name	International Society for Stem Cell Research
Abbreviation	ISSCR
Formation	2002
Type	Professional association
Headquarters	Philadelphia
Region served	International
Leader title	President

International Society for Stem Cell Research is a professional organization dedicated to the advancement of stem cell science, regenerative medicine, and related ethical, legal, and social issues. The society promotes standards for research integrity and clinical translation while convening scientists, clinicians, ethicists, and policymakers from institutions such as Harvard University, Stanford University, University of Cambridge, University of Oxford, and University of Tokyo. It engages with international bodies including the World Health Organization, National Institutes of Health, European Commission, Food and Drug Administration (United States), and United Nations forums.

History

Founded in 2002, the society emerged amid debates involving figures and entities like James Thomson (biologist), Shinya Yamanaka, Gurdon, National Academies of Sciences, Engineering, and Medicine, and institutions such as The Rockefeller University and Johns Hopkins University. Early organizational milestones coincided with landmark publications from journals like Nature (journal), Science (journal), Cell (journal), and interactions with research centers at Cambridge Biomedical Campus, Broad Institute, and Gladstone Institutes. The society’s development paralleled policy shifts seen in responses to legislation like the Stem Cell Research Enhancement Act and high-profile events involving Harvard Stem Cell Institute, California Institute for Regenerative Medicine, and national advisory panels including the President's Council on Bioethics.

Mission and Objectives

The society’s mission aligns with objectives championed by organizations such as International Council for Laboratory Animal Science, Organisation for Economic Co-operation and Development, Wellcome Trust, and Howard Hughes Medical Institute: advancing basic research exemplified by labs at MIT, accelerating safe clinical trials associated with hospitals like Mayo Clinic and Cleveland Clinic, and shaping policy dialogues involving European Medicines Agency and National Health Service (England). Objectives include standard-setting referenced by publications from The Lancet, professional training akin to programs at Karolinska Institutet and University of California, San Francisco, and cross-sector partnerships with industry leaders such as Roche, Novartis, Pfizer, and startups emerging from Silicon Valley incubators.

Governance and Membership

Governance structures mirror practices at societies such as American Society for Cell Biology, Royal Society, and American Association for the Advancement of Science with elected officers, a board comparable to boards at Wellcome Trust and committees interacting with advisory groups like Ethics Committee of the International Red Cross. Membership encompasses researchers from Columbia University, clinicians from Massachusetts General Hospital, trainees associated with Salk Institute for Biological Studies, and affiliates linked to national academies like Chinese Academy of Sciences and Max Planck Society. Partnerships and liaisons extend to regulatory agencies including Medicines and Healthcare products Regulatory Agency and philanthropic funders like Gates Foundation.

Annual Meetings and Conferences

Annual meetings attract participants from institutions including Yale University, Princeton University, University of Pennsylvania, University of California, Los Angeles, and international centers such as RIKEN, National University of Singapore, and University of Melbourne. Programs feature keynote talks by laureates connected to Nobel Prize winners like John Gurdon and Shinya Yamanaka, symposia modeled on conferences like Cold Spring Harbor Laboratory meetings, and workshops co-organized with organizations such as European Society for Medical Oncology and American Society of Clinical Oncology. These events also intersect with translational initiatives at hospitals like Johns Hopkins Hospital and regulatory briefings involving U.S. Congress committees and national ministries of health.

Guidelines and Policy Statements

The society is known for issuing guidelines influencing practice at institutions such as Memorial Sloan Kettering Cancer Center and policy frameworks referenced by World Health Organization task forces, National Institutes of Health advisory panels, and committees at European Commission. Its statements address topics that have engaged actors like StemCells, Inc., Geron Corporation, Advanced Cell Technology, and national regulatory disputes (e.g., debates paralleling rulings in United States District Court for the District of Columbia). Documents cover human embryo research, chimeras, gene editing in human embryos involving CRISPR-Cas9 discourse, and clinical translation standards cited by journals such as New England Journal of Medicine.

Education, Outreach, and Funding Programs

Educational initiatives include training fellowships, summer courses comparable to programs at Cold Spring Harbor Laboratory and collaborations with universities such as University of Toronto and University of British Columbia. Outreach efforts engage patient advocacy groups like Cure Parkinson's and Alzheimer's Association, media outlets including BBC, The New York Times, and philanthropic partners similar to Simons Foundation. The society coordinates funding awareness for early-career researchers seeking grants from agencies like National Science Foundation, regional funders such as Canadian Institutes of Health Research, and private funders exemplified by Wellcome Trust and Howard Hughes Medical Institute.

Impact and Controversies

The society’s impact is reflected in shaping translational pathways used by biotech firms including Bluebird Bio and academic-industry partnerships at Biogen while controversies have involved high-profile disputes over clinical claims similar to cases with Stamina Foundation and regulatory scrutiny faced by firms like Celltex Therapeutics. Debates over ethical frameworks echo controversies around embryo research involving legal cases in jurisdictions like United Kingdom, United States, and Japan, and scientific reproducibility concerns highlighted in discussions involving Retraction Watch and journal editorial policies at Nature (journal) and Science (journal). The society’s responses have included updates to guidance, collaboration with oversight bodies such as Institutional Review Board equivalents, and engagement with international ethics debates involving panels convened by UNESCO.

Category:Scientific organizations